PF-Atlas › Clinical Trials › NCT07762885

Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery

Adjuvant Radiotherapy · Phase 3

Registry ID
NCT07762885
Phase
Phase 3
Status
Recruiting
Drug / intervention
Adjuvant Radiotherapy
Sponsor
Fudan University
Start
2026-07-01

About this trial

Adjuvant Radiotherapy is evaluated in NCT07762885, a Phase 3 idiopathic pulmonary fibrosis study sponsored by Fudan University. Current status: Recruiting.

View NCT07762885 on ClinicalTrials.gov →

Explore related

All Adjuvant Radiotherapy trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT07762885 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.